Your browser doesn't support javascript.
loading
[Preclinical application of MR and fluorescent dual-modality imaging combined with photothermal therapy in HER-2 positive breast cancer].
Luo, X J; Li, J; Zhou, C W.
Affiliation
  • Luo XJ; Department of Diagnostics Radiology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China.
  • Li J; Department of Diagnostics Radiology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China.
  • Zhou CW; Department of Diagnostics Radiology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China.
Zhonghua Zhong Liu Za Zhi ; 40(8): 587-593, 2018 Aug 23.
Article in Zh | MEDLINE | ID: mdl-30139028
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Phototherapy / Breast Neoplasms / Receptor, ErbB-2 / Nanoconjugates / Trastuzumab / Antineoplastic Agents, Immunological Language: Zh Journal: Zhonghua Zhong Liu Za Zhi Year: 2018 Type: Article Affiliation country: China
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Phototherapy / Breast Neoplasms / Receptor, ErbB-2 / Nanoconjugates / Trastuzumab / Antineoplastic Agents, Immunological Language: Zh Journal: Zhonghua Zhong Liu Za Zhi Year: 2018 Type: Article Affiliation country: China